enGene Therapeutics (ENGN) Invested Capital (2022 - 2026)
enGene Therapeutics (ENGN) posted Invested Capital of $255.64 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 14.2% from $223.79 million a year earlier but down 8.8% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Invested Capital (2022 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics' Invested Capital came in at $191.04 million, down 35.4% from FY2024.
- In prior fiscal years, enGene Therapeutics' Invested Capital was $295.78 million in FY2024 (+259.6%), $82.26 million in FY2023 and -$65.7 million in FY2022.
- Quarterly Invested Capital has run from a low of -$65.7 million in fiscal Q4 2022 to a high of $306.47 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, Invested Capital has increased in each of the last three quarters, with growth averaging 58.4% over the last eight quarters.
- The strongest year-over-year quarter for Invested Capital in the past five years was fiscal Q4 2024, with growth of 259.6%; the weakest was fiscal Q4 2025, with a decline of 35.4%.
- According to Business Quant data, Invested Capital for the three prior fiscal quarters was $280.27 million (Q2 2026), $306.47 million (Q1 2026) and $191.04 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 255.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 255.64 Mn |
| Apr 30, 2026 | 280.27 Mn |
| Jan 31, 2026 | 306.47 Mn |
| Oct 31, 2025 | 191.04 Mn |
| Jul 31, 2025 | 223.79 Mn |
| Apr 30, 2025 | 250.88 Mn |
| Jan 31, 2025 | 273.34 Mn |
| Oct 31, 2024 | 295.78 Mn |
| Jul 31, 2024 | 253.28 Mn |
| Apr 30, 2024 | 265.70 Mn |
| Jan 31, 2024 | 84.91 Mn |
| Oct 31, 2023 | 82.26 Mn |
| Jul 31, 2023 | -53.94 Mn |
| Oct 31, 2022 | -65.70 Mn |
API Access
enGene Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();